No Data
Wanbang Medicine (301520.SZ): has repurchased a total of 0.61% of its shares.
As of May 7, 2023, Wanbang Pharmaceutical (301520.SZ) announced that by April 30, 2025, the company's dedicated securities account for share repurchase had cumulatively repurchased 404,900 shares through centralized bidding, accounting for 0.61% of the company's total share capital, with a highest Fill Price of 40.80 yuan/share, a lowest Fill Price of 34.56 yuan/share, and a total repurchase amount of 15.233438 million yuan (excluding transaction fees).
We Believe That Anhui Wanbang Pharmaceutical TechnologyLtd's (SZSE:301520) Weak Earnings Are A Good Indicator Of Underlying Profitability
Wanbang Pharmaceutical: 2024 Annual Report
Wanbang Pharmaceutical: 2024 Annual Report Summary
Wanbang Pharmaceutical: Report for the first quarter of 2025
Wanbang Pharmaceutical (301520.SZ) released its first-quarter results, with a net income of 11.8493 million yuan, a decrease of 60.09%.
Wanbang Pharmaceutical (301520.SZ) released the first quarter report for 2025, with the company's revenue of 7105...